Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFE Trial
NCT04738318Phase 4Terminated
- Sponsor
- Vanderbilt University Medical Center
- Start
- Jun 2022
- Primary completion
- Mar 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dexamethasone, methylprednisolone injection in elbow fracture, sponsored by Vanderbilt University Medical Center. Started Jun 2022; status: terminated.
02
Drugs
dexamethasonemethylprednisolone injection
03
Conditions
elbow fracture
Beyond the preview
Go deeper on NCT04738318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04738318.